AB012. A phase III randomized trial of gross total resection versus possible resection of fluid-attenuated inversion recovery (FLAIR) hyperintensity lesion on magnetic resonance image for newly diagnosed supratentorial glioblastoma (JCOG2209).

AB012 - Aronora

temozolomide - Generic mfg.

http://www.ncbi.nlm.nih.gov/pubmed/39295330

Haruhiko Fukuda; Hiroshi Igaki; Ichiyo Shibahara; Junji Shibahara; Junki Mizusawa; Keita Sasaki; Koichi Ichimura; Manabu Kinoshita; Mayumi Ichikawa; Tetsuya Sekita; Yoshiki Arakawa; Yoshitaka Narita; Yukihiko Sonoda; Yuta Sekino

Sep 21, 2024